China Contraceptive Devices Market: Market Size & Forecast 2026

The market encompasses non-pharmaceutical contraceptive products distributed through hospitals, clinics, pharmacies, and consumer retail channels in China. Devices such as condoms and IUDs together account for the bulk of category revenue, reflecting China's long-standing preference for long-acting and barrier methods. At USD 0.76 billion in 2025, China represents a significant share of the Asia Pacific contraceptive devices space, the fastest-growing major region in the global category.

• •Market size estimated at USD 0.76 billion in 2025, projected to reach USD 1.02 billion by 2030.
• •China anchors Asia Pacific, the fastest-growing region in the global contraceptive devices category.
• •IUDs and condoms remain the dominant product categories by revenue.

Demand is supported by a population base of more than 600 million women of reproductive age, alongside rising disposable incomes and greater willingness among younger consumers to purchase contraceptive products outside of public-sector channels. Public-health initiatives, expanding sex-education programs, and growing female workforce participation are reinforcing uptake of modern methods. The rapid scaling of e-commerce platforms has also made devices more accessible in lower-tier cities and rural areas.

• •A large reproductive-age cohort and rising sexual-health awareness underpin baseline demand.
• •Government family-planning infrastructure continues to favor IUDs and other device-based methods.
• •Online retail expansion is broadening access beyond urban hospital and pharmacy networks.

By product type, the market is led by condoms and intrauterine devices, with diaphragms, sponges, and other mechanical methods making up a smaller residual share. Tier-1 cities such as Beijing, Shanghai, Guangzhou, and Shenzhen contribute the highest per-capita spending, while Tier-2 and Tier-3 cities represent the fastest-growing demand pockets as awareness and disposable income rise. Coastal and eastern provinces account for the majority of revenue, with central and western regions catching up as healthcare access improves.

• •Condoms and IUDs are the two largest product segments by value.
• •Eastern coastal provinces dominate revenue, while inland regions are growing fastest.
• •Tier-1 cities lead per-capita consumption; Tier-2 and Tier-3 cities drive incremental growth.

What are the recent trends and outlook?

The market is expected to continue compounding at roughly 6% annually through 2030, in line with broader contraceptive demand growth in China. Key forward-looking trends include premiumization of condoms, gradual diversification of product types beyond condoms and IUDs, and deeper digital sales penetration. While demographic headwinds, including a declining national birth rate, may cap long-term volume growth in some segments, rising per-user spend and product innovation are expected to sustain value growth over the forecast horizon.

• •Premium condom lines and branded SKUs are gaining share as consumers trade up.
• •E-commerce is set to become the dominant channel for over-the-counter device purchases.
• •Value growth is increasingly driven by per-user spending rather than first-time user expansion.